Gala vs MEDGm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 1, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

53 providers verified independently·Independent research·How we rank →

Short answer: Gala scores higher on our rubric, 7.2/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Gala - our pick of these two →or find your match

Gala beats MEDGm overall, scoring 7.2/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; MEDGm is from $179/mo. Choose Gala for tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.

A side-by-side look at Gala and MEDGm to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Gala

#31 of 53

7.2/10

Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.

Visit Gala

MEDGm

#53 of 53

2.7/10

MEDGm is a telehealth company selling compounded GLP-1 injections from $179/mo and dissolvable tablets from $249/mo, with brand-name Zepbound, Wegovy and Ozempic offered as a membership plus an unpublished medication cost. The compounded prices are readable before intake and the not-FDA-approved disclosure is prominent, which is more than several better-known programs manage. The gap is verification: no clinician, no pharmacy and no accreditation is named anywhere on the site or in its terms.

Visit MEDGm

Feature	Gala	MEDGm
Why each one	The dedicated 'Gala GLP-1 Tracker' app on BOTH iOS and Android, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; most compounded-only platforms offer neither a first-party tracking experience nor an explicit microdose pricing tier.	Publishes its compounded prices before intake and does not claim an accreditation it cannot support. Both are low bars that a surprising number of programs fail.
Our Score	7.2/10	2.7/10
Headline Price	from $149/mo	from $179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Tirzepatide-first patients who want a lower yearly-plan rate (microdose $149/mo or full-dose $179/mo) plus a dedicated iOS + Android tracker app for daily progress logging	Shoppers who want a compounded GLP-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.
Watch out for	Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide.	No medical director, prescribing clinician or medical group is named anywhere
Ranking	#31	#53
Get started	Visit Gala	Visit MEDGm

Pros & Cons Compared

Gala

Pros

+Compounded tirzepatide is $149/mo microdose or $179/mo full-dose on the yearly plan; 3-month pricing is $169/mo microdose or $219/mo full-dose
+Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide.
−Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
−Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
−Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

MEDGm

Pros

+Compounded prices visible on the landing page without starting an intake
+Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
+Cancel any time, with a published refund policy rather than a buried one
+Claims no accreditation it cannot support, which is rarer than it should be
+HSA/FSA accepted; free shipping stated

Cons

−No medical director, prescribing clinician or medical group is named anywhere
−No compounding pharmacy is named; the terms promise a partner list that the terms do not contain
−Brand-name Zepbound, Wegovy and Ozempic are priced as a membership plus an unpublished medication cost, so no brand total can be compared
−No lab panel is offered or required at any tier
−The homepage claims 120,000+ patients on a domain registered 2026-04-08; we could not reconcile the two
−A prepaid contracted term is non-refundable, and dispensed medication is never refundable
−No third-party rating exists that we could locate and verify

Our Verdict

Gala edges out MEDGm with a score of 7.2/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; MEDGm is from $179/mo.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Gala and MEDGm start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.